Jennison Associates LLC Astrazeneca PLC Transaction History

Jennison Associates LLC

$160 Billion
Q3 2024

A detailed history of Jennison Associates LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jennison Associates LLC holds 14,964,547 shares of AZN stock, worth $997 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

14,964,547

Previous 17,023,655 12.1%

Holding current value

$997 Million

Previous $1.33 Billion 12.17%

% of portfolio

0.73%

Previous 0.85%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$76.67 - $87.62 $158 Million - $180 Million	-2,059,108 Reduced 12.1%	14,964,547 $1.17 Billion
Q2 2024 Aug 05, 2024	SELL	$66.81 - $80.83 $16.9 Million - $20.4 Million	-252,627 Reduced 1.46%	17,023,655 $1.33 Billion
Q1 2024 May 02, 2024	SELL	$61.03 - $69.57 $27.8 Million - $31.7 Million	-456,260 Reduced 2.57%	17,276,282 $1.17 Billion
Q4 2023 Feb 01, 2024	SELL	$61.89 - $69.28 $323 Million - $361 Million	-5,213,962 Reduced 22.72%	17,732,542 $1.19 Billion
Q3 2023 Oct 31, 2023	BUY	$64.85 - $71.7 $73.9 Million - $81.7 Million	1,139,295 Added 5.22%	22,946,504 $1.55 Billion
Q2 2023 Aug 03, 2023	BUY	$69.91 - $75.81 $393 Million - $426 Million	5,617,054 Added 34.69%	21,807,209 $1.56 Billion
Q1 2023 Apr 26, 2023	BUY	$63.15 - $71.6 $688 Million - $780 Million	10,895,302 Added 205.77%	16,190,155 $1.12 Billion
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $46.3 Million - $60.1 Million	853,190 Added 19.21%	5,294,853 $359 Million
Q3 2022 Nov 01, 2022	BUY	$53.02 - $135.75 $17.3 Million - $44.3 Million	326,337 Added 7.93%	4,441,663 $244 Million
Q2 2022 Aug 02, 2022	BUY	$59.26 - $71.14 $27.1 Million - $32.6 Million	457,836 Added 12.52%	4,115,326 $272 Million
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $46.7 Million - $56.2 Million	837,575 Added 29.7%	3,657,490 $243 Million
Q4 2021 Feb 08, 2022	SELL	$54.02 - $63.83 $12.4 Million - $14.6 Million	-228,903 Reduced 7.51%	2,819,915 $164 Million
Q3 2021 Nov 09, 2021	SELL	$55.56 - $60.79 $1,166 - $1,276	-21 Reduced -0.0%	3,048,818 $183 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $5.65 Million - $7.02 Million	116,660 Added 3.98%	3,048,839 $183 Million
Q1 2021 May 11, 2021	SELL	$47.16 - $54.44 $330 Million - $381 Million	-6,993,091 Reduced 70.46%	2,932,179 $146 Million
Q4 2020 Feb 05, 2021	SELL	$48.52 - $58.02 $1.02 Billion - $1.22 Billion	-21,110,188 Reduced 68.02%	9,925,270 $496 Million
Q3 2020 Nov 04, 2020	SELL	$53.07 - $61.1 $430 Million - $495 Million	-8,098,278 Reduced 20.69%	31,035,458 $1.7 Billion
Q2 2020 Aug 06, 2020	BUY	$43.1 - $55.31 $14.3 Million - $18.3 Million	331,613 Added 0.85%	39,133,736 $2.07 Billion
Q1 2020 May 06, 2020	BUY	$37.79 - $51.33 $81.2 Million - $110 Million	2,148,165 Added 5.86%	38,802,123 $1.73 Billion
Q4 2019 Feb 07, 2020	BUY	$42.46 - $50.46 $28.4 Million - $33.8 Million	669,273 Added 1.86%	36,653,958 $1.83 Billion
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $84.1 Million - $95.3 Million	2,096,600 Added 6.19%	35,984,685 $1.6 Billion
Q2 2019 Aug 06, 2019	SELL	$37.28 - $41.68 $357 Million - $399 Million	-9,574,056 Reduced 22.03%	33,888,085 $0
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $82.9 Million - $100 Million	-2,334,646 Reduced 5.1%	43,462,141 $1.76 Billion
Q4 2018 Feb 06, 2019	BUY	$36.86 - $41.49 $223 Million - $251 Million	6,052,483 Added 15.23%	45,796,787 $1.74 Billion
Q3 2018 Nov 08, 2018	BUY	$34.76 - $39.72 $712 Million - $813 Million	20,470,137 Added 106.21%	39,744,304 $1.57 Billion
Q2 2018 Aug 02, 2018	BUY	$34.55 - $37.05 $666 Million - $714 Million	19,274,167 New	19,274,167 $677 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Astrazeneca PLC Transaction History